BiondVax Pharmaceuticals Ltd.
Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine
Published in Vaccine Weekly, December 23rd, 2009
-- The antibodies generated by the vaccine specifically identified
several strains of influenza, including the swine flu strain
-- BiondVax's CEO Dr. Ron Babecoff: "This is an important indication
along the way towards the realization of the Company's vision of
ensuring protection against all flu strains with a single
Keywords: Biotechnology, Clinical Trial Research, Flu Vaccines, Immunization, Influenza Vaccines, Pharmaceuticals, Therapy, Treatment, Vaccination, BiondVax Pharmaceuticals Ltd.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-12-23)
More Articles from Vaccine Weekly
- Allograft Rejection
Reports from Emory University, Emory Vaccine Center add new data to research in allograft rejection - Alzheimer Disease
Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease - Encephalitis
Findings from T. Jelinek and co-researchers advance knowledge in encephalitis - Epidemics
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America - Hepatitis A Virus
Reports outline hepatitis A virus research from M.S. Faber and colleagues - Hepatitis A Virus
Studies from Berna Biotech Ltd. have provided new data on hepatitis A virus - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
